Our clinical trial success speaks about our core expertise in assessment of diseases with unmet clinical need combined with our speed of research translating into safe and effective bed side treatment for patients. Our scientific and technical teams have been part of several inter-ministerial committees responsible for creating regulatory framework and standards for stem cell and cellbased products.

Through our strong 340 doctor-partner networks across 46 cities, we have been able to serve 1500 patients who have had a life-changing experience and now lead an active lifestyle with many being sports professionals.

Being true to our vision of becoming the world's largest stem cell and organ development factory, we are actively pursuing the next generation stem cell platform which promises to be universal and off-the-shelf. We are continuously innovating and publishing our original research in areas of hematopoietic transplantation, cell potency assays, HLA inventory, inhibitory effects of intraarticular steroid use, gene mutations offering a potential HIV cure and many more.